Interleukin gene polymorphisms in pneumoconiosis

Helmig,Simone; Grossmann,Martin; Wübbeling,Jelena; Schneider,Joachim

doi:10.3892/ijmm.2012.996

Interleukin gene polymorphisms in pneumoconiosis

Authors:
- Simone Helmig
- Martin Grossmann
- Jelena Wübbeling
- Joachim Schneider
View Affiliations

Affiliations: Institute and Polyclinic for Occupational and Social Medicine, Justus-Liebig University, D-35392 Giessen, Germany
Published online on: May 10, 2012 https://doi.org/10.3892/ijmm.2012.996
Pages: 401-408

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inhaled asbestos fibres are known to cause inflammation processes with the result of lung or pleural fibrosis and malignancies. Interleukins (IL), such as IL-1β, IL-6 and IL-10, have various functions in the regulation of the inflammatory response and in proliferative processes after inhalation of silica dust and can, therefore, influence the pathogenesis of asbestos-induced fibrosis and carcinogenesis. Polymorphisms within these genes may be associated with susceptibility to silica and asbestos-induced lung diseases. Thus, IL-1β, IL-6 and IL-10 polymorphisms were examined to determine an association with asbestos or silica-induced fibrosis or malignancies. Association studies were performed in 1180 individuals, using control subjects (n=177), fibrosis patients (n=605), lung cancer (LC) patients (n=364) and malignant mesothelioma (MM) patients (n=34). IL-1β (C-511T; C+3954T), IL-6 (G-174C) as well as IL-10 (G-1082A) polymorphisms were investigated. Compared to a healthy (control) group, a higher risk was seen for malignant mesothelioma patients in all investigated polymorphisms. The IL-6 -174C allele showed a tendency towards a higher risk for fibrosis or asbestos-induced lung cancer (ORasbestosis, 1.338; 95% CI, 0.71-2.53; ORsilicosis, 1.226; 95% CI, 0.54-2.81; ORfibrosis other aetiology, 1.313; 95% CI, 0.58-2.98 and ORLC asbestos, 2.112; 95% CI, 0.75-5.92). The IL-10 -1082A carrier seemed to be at higher risk for silicosis (ORsilicosis, 2.064; 95% CI, 0.78-5.49) but not for asbestosis. In summary, this study did not reveal sufficient evidence for a significant association of the investigated interleukin polymorphisms with asbestos or silica-induced diseases in the population studied.

View Figures

View References

1.	DW KampAsbestos-induced lung diseases: an updateTransl Res153143152200910.1016/j.trsl.2009.01.00419304273
2.	J SchneiderR ArhelgerG Hauser-HeidtWertigkeit der statischen Compliance-Messung bei Asbestfaserstaub-verursachten Erkrankungen der Lunge und der PleuraWissenschaftlicher Abschlußbericht1792006(In German).
3.	CB ManningV VallyathanBT MossmanDiseases caused by asbestos: mechanisms of injury and disease developmentInt Immunopharmacol2191200200210.1016/S1567-5769(01)00172-211811924
4.	C DostertV PetrilliR Van BruggenC SteeleBT MossmanJ TschoppInnate immune activation through Nalp3 inflammasome sensing of asbestos and silicaScience320674677200810.1126/science.115699518403674
5.	I AtesB YucesoyA YucelSH SuzenY KarakasA KarakayaPossible effect of gene polymorphisms on the release of TNF alpha and IL1 cytokines in coal workers’ pneumoconiosisExp Toxicol Pathol63175179201120005085
6.	A WeberP WasiliewM KrachtInterleukin-1 (IL-1) pathway (Review)Sci Signal3cm12010
7.	A WeberP WasiliewM KrachtInterleukin-1beta (IL-1beta) processing pathway (Review)Sci Signal3cm2201020086236
8.	E VoronovDS ShouvalY KrelinIL-1 is required for tumor invasiveness and angiogenesisProc Natl Acad Sci USA10026452650200310.1073/pnas.043793910012598651
9.	Y KrelinE VoronovS DotanInterleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumorsCancer Res6710621071200710.1158/0008-5472.CAN-06-295617283139
10.	DM ElarajDM WeinreichS VargheseThe role of interleukin 1 in growth and metastasis of human cancer xenograftsClin Cancer Res1210881096200610.1158/1078-0432.CCR-05-160316489061
11.	K BhattacharyaE DoppP KakkarBiomarkers in risk assessment of asbestos exposureMutat Res579621200510.1016/j.mrfmmm.2005.02.02216112146
12.	MI LusterPP SimeonovaAsbestos induces inflammatory cytokines in the lung through redox sensitive transcription factorsToxicol Lett102–103271275199810022265
13.	R ZhaiG LiuX GeSerum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin 6 (IL-6), and their soluble receptors in coal workers’ pneumoconiosisRespir Med96829834200212412984
14.	FA HoussiauJP DevogelaerJ Van DammeCN de DeuxchaisnesJ Van SnickInterleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritidesArthitis Rheum31784788198810.1002/art.17803106143260102
15.	PC TrevilattoRM Scarel-CaminagaRB de Brito JrAP de SouzaSR LinePolymorphism at position −174 of IL-6 gene is associated with susceptibility to chronic periodontitis in a Caucasian Brazilian populationJ Clin Periodontol304384422003
16.	RM GrossmanJ KruegerD YourishInterleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytesProc Natl Acad Sci USA8663676371198910.1073/pnas.86.16.63672474833
17.	J BidwellL KeenG GallagherCytokine gene polymorphism in human disease: on-line databasesGenes Immun1319199910.1038/sj.gene.6363645
18.	J BidwellL KeenG GallagherCytokine gene polymorphism in human disease: on-line databases, supplement 1Genes Immun26170200110.1038/sj.gene.636373311393658
19.	MV HollegaardJL BidwellCytokine gene polymorphism in human disease: on-line databases, Supplement 3Genes Immun7269276200610.1038/sj.gene.636430116642032
20.	SK HallDG PerregauxCA GabelCorrelation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta proteinArthritis Rheum5019761983200410.1002/art.2031015188375
21.	F PociotJ MolvigL WogensenH WorsaaeJ NerupA TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitroEur J Clin Invest22396402199210.1111/j.1365-2362.1992.tb01480.x1353022
22.	D FishmanG FauldsR JefferyThe effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritisJ Clin Invest10213691376199810.1172/JCI26299769329
23.	R SabatG GrutzK WarszawskaBiology of interleukin-10Cytokine Growth Factor Rev21331344201010.1016/j.cytogfr.2010.09.002
24.	KW MooreR de Waal MalefytRL CoffmanA O’GarraInterleukin-10 and the interleukin-10 receptorAnnu Rev Immunol19683765200110.1146/annurev.immunol.19.1.68311244051
25.	A SuarezP CastroR AlonsoL MozoC GutierrezInterindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphismsTransplantation75711717200310.1097/01.TP.0000055216.19866.9A
26.	American Thoracic SocietyIdiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)Am J Respir Crit Care Med161646664200010.1164/ajrccm.161.2.ats3-00
27.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasThis joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001Am J Respir Crit Care Med165277304200210.1164/ajrccm.165.2.ats01
28.	WD TravisTumours of the Lung, Pleura, Thymus and HeartIARC PressLyon9562004
29.	KG HeringM JacobsenE Bosch-GaletkeFurther development of the International Pneumoconiosis Classification - from ILO 1980 to ILO 2000 and to ILO 2000/German Federal Republic versionPneumologie575765842003(In German).
30.	BT MossmanA ChurgMechanisms in the pathogenesis of asbestosis and silicosisAm J Respir Crit Care Med15716661680199810.1164/ajrccm.157.5.97071419603153
31.	P NymarkH WikmanT Hienonen-KempasS AnttilaMolecular and genetic changes in asbestos-related lung cancerCancer Lett265115200810.1016/j.canlet.2008.02.04318364247
32.	J SanceauJ WijdenesM RevelJ WietzerbinIL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gammaJ Immunol1472630263719911918983
33.	F HuauxM ArrasA VinkJC RenauldD LisonSoluble tumor necrosis factor (TNF) receptors p55 and p75 and inter-leukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI miceAm J Respir Cell Mol Biol21137145199910.1165/ajrcmb.21.1.357010385602
34.	S HelmigN AliahmadiJ SchneiderTumour necrosis factor-alpha gene polymorphisms in asbestos-induced diseasesBiomarkers15400409201010.3109/1354750X.2010.48136520486865
35.	S HelmigA BelweJ SchneiderAssociation of transforming growth factor beta1 gene polymorphisms and asbestos-induced fibrosis and tumorsJ Investig Med57655661200919349911
36.	B YucesoyV VallyathanDP LandsittelP SimeonovaMI LusterCytokine polymorphisms in silicosis and other pneumoconiosesMol Cell Biochem234–235219224200212162437
37.	C KiyoharaT HoriuchiK TakayamaY NakanishiIL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese populationJ Thorac Oncol5299304201010.1097/JTO.0b013e3181c8cae320035239
38.	DA PapanicolaouRL WilderSC ManolagasGP ChrousosThe pathophysiologic roles of interleukin-6 in human diseaseAnn Intern Med128127137199810.7326/0003-4819-128-2-199801150-000099441573
39.	B SchluterC RaufhakeM ErrenEffect of the interleukin-6 promoter polymorphism (−174 G/C) on the incidence and outcome of sepsisCrit Care Med3032372002
40.	I AtesHS SuzenB YucesoyIO TekinA KarakayaAssociation of cytokine gene polymorphisms in CWP and its severity in Turkish coal workersAm J Ind Med51741747200810.1002/ajim.2063218702109
41.	DM TurnerDM WilliamsD SankaranM LazarusPJ SinnottIV HutchinsonAn investigation of polymorphism in the interleukin-10 gene promoterEur J Immunogenet2418199710.1111/j.1365-2370.1997.tb00001.x9043871
42.	AR TamburJW OrtegelZ Ben-AriRole of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipientsTransplantation7114751480200110.1097/00007890-200105270-0002011391238
43.	C PerreyV PravicaPJ SinnottIV HutchinsonGenotyping for polymorphisms in interferon-gamma, interleukin-10, transforming growth factor-beta 1 and tumour necrosis factor-alpha genes: a technical reportTranspl Immunol6193197199810.1016/S0966-3274(98)80045-29848226
44.	C SeifartA PlagensA DempfleTNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancerDis Markers21157165200510.1155/2005/70713116276011
45.	CM ShihYL LeeHL ChiouThe involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancerLung Cancer50291297200510.1016/j.lungcan.2005.07.00716122836
46.	Y ZhouW HuW ZhuangX WuInterleukin-10 −1082 promoter polymorphism and gastric cancer risk in a Chinese Han populationMol Cell Biochem34789932010
47.	EK SilvermanLJ PalmerCase-control association studies for the genetics of complex respiratory diseasesAm J Respir Cell Mol Biol22645648200010.1165/ajrcmb.22.6.f19110837359
48.	J ParkerRadiological criteria: the use of chest imaging techniques in asbestos-related diseasesProceedings of an International Expert Meeting on Asbestos, Asbestosis and Cancer, People and Work, Research ReportsFinnish Institute of Occupational HealthHelsinki28401997
49.	P DeVuystGuidelines for attribution of lung cancer to asbestosProceedings of an International Expert Meeting on Asbestos, Asbestosis and Cancer, People and Work, Research ReportsFinnish Institute of Occupational HealthHelsinki92961997